Collegium Pharmaceutical, Inc
Pharmaceutical company · Stoughton, Massachusetts, United States · Nasdaq: COLL
Collegium Pharmaceutical, Inc is a pharmaceutical company headquartered in Stoughton, Massachusetts, United States. Its shares trade on Nasdaq under the ticker COLL. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $472,811 in total, most recently in 2014. It has reported private securities offerings to the US SEC, most recently $20 million sold in a notice filed in 2018.
Collegium Pharmaceutical at a glance
What does Collegium Pharmaceutical do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $472,811 in total (2014).
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $20 million sold (2018).
Frequently asked questions about Collegium Pharmaceutical
Where is Collegium Pharmaceutical headquartered?
Collegium Pharmaceutical, Inc is headquartered in Stoughton, Massachusetts, United States.
What does Collegium Pharmaceutical do?
Collegium Pharmaceutical, Inc is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Collegium Pharmaceutical a public company?
Yes. Collegium Pharmaceutical, Inc trades on Nasdaq under the ticker COLL.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.